[1]
Bożek, A. 2025. Safety of using the 300 IR tablet containing house dust mite allergens for sublingual immunotherapy. Alergoprofil. 20, 4 (Apr. 2025), 9-12. DOI:https://doi.org/10.24292/01.AP.204100525.